NCT05516784View on ClinicalTrials.gov

Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions
Coronary Artery Disease (CAD)
Interventions
DRUG

Clopidogrel

Comparison of platelet reactivity between clopidogrel and ticagrelor

DRUG

Ticagrelor

Comparison of platelet reactivity between clopidogrel and ticagrelor

Trial Locations (1)

10990

Department of Cardiology, Penang General Hospital, George Town

All Listed Sponsors
lead

Universiti Sains Malaysia

OTHER

NCT05516784 - Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile | Biotech Hunter | Biotech Hunter